| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INC COM | 82,723 | 2,685,000 | 20.75% | ||
| 2 | LILLY ELI & CO | 26,810 | 2,111,000 | 16.32% | ||
| 3 | EDWARDS LIFESCIENCES CORP | 18,611 | 1,856,000 | 14.35% | ||
| 4 | JOHNSON & JOHNSON | 13,000 | 1,577,000 | 12.19% | ||
| 5 | ALIGN TECHNOLOGY INC | 17,319 | 1,395,000 | 10.78% | ||
| 6 | ARATANA THERAPEUTICS INC COM | 218,515 | 1,381,000 | 10.67% | ||
| 7 | ALEXION PHARMACEUTIC | 8,599 | 1,004,000 | 7.76% | ||
| 8 | DEXCOM | 11,700 | 928,000 | 7.17% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003616, filed 2016.07.27).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
